Background: Diabetic retinopathy (DR) is one of the common microvascular complications of diabetes and it is the most common cause of preventable blindness in developing countries. In diabetic patients other than hyperglycemia, dyslipidemia is an important, but often overlooked factor in the development of DR.
Objectives: To investigate the association of dyslipidemia with development of diabetic retinopathic complications.
Material and Methods: This hospital based cross sectional study included 150 diabetic patients who visited tertiary health care center in Gujarat. Demographic, clinical details were obtained; participants were evaluated for HbAlc, lipid profile and status of diabetic retinopathy. Multiple logistic regression analysis was used to analyze statistical correlation between dyslipidemia and diabetic retinopathy.
Results: In diabetic retinopathy patients derangement of lipid levels in form of low levels of HDL C<40mg/dl was present in 46.66% patients followed by serum triglycerides>160mg/dl was present in 43.33% patients. 33% patients was found with raised LDL>130mg/dl. Diabetic retinopathy was found to have significant correlation with duration of disease, fasting blood sugar and low levels of HDL.
Conclusion: Low levels of HDL along with fasting blood sugar level and duration of disease in type II diabetes are significantly associated with severity and progression of diabetic retinopathy. This could explain the failure of intensive glycemic control in reducing retinopathic complications observed in some studies. Hence, appropriate preventive and treatment strategies should be considered timely.
Ezhilvendhan K, Sathiyamoorthy A, Prakash BJ, Bhava BS, Shenoy A. Association of dyslipidemia with diabetic retinopathy in Type 2 diabetes mellitus patients: A hospital-based study. J Pharm Bio all Sci 2021;13:Sl 062-7.
World Health Organisation (WHO). Diabetes. Available from: https://www.who.int/health-topics/diabetes#tab=tabl. [Accessed on December 26, 2020]
Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989;38: 1203-6.
Hammes HP, Lin J, Renner 0, Shani M, Lundqvist A, Betsholtz C, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002;51:3107-12.
Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care 2003;26:226-9.
Busik N, Reid GE, Lydic TA. Global analysis of retina lipids by complementary precursor ion and neutral loss mode tandem mass spectrometry. Methods Mol Biol 2009;579:33-70.
Hegde SS, Vekategowda HT. Association of lipid profile with diabetic retinopathy - A comparative study. Int J Health Sci Res. 2016;6:74-81
Jenchitr W, Samaipom S, Lertmeemongkolchai P, Chongwiriyanurak T, Anujaree P, Chayaboon D et al. Prevalence of diabetic retinopathy in relation to duration of diabetes mellitus in community hospitals of Lampang. J Med Assoc Thai 2004;87(11):1321-6.
Klein R, Knudtson MD, Lee KE, Gagnon R, Klein BEK. The Wisconsin epidemiologic study of diabetic retinopathy XXII: The Twenty-Five-Year Progression of Retinopathy in Persons with Type 1 Diabetes. Ophthalmology 2008; 115(11): 1859-68.
United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in over weight patients with type 2 diabetes mellitus (UKPDS 34). Lancet 1998;352:85465.
Al-Shammari FKH, Al-Meraghi 0, Nasif A, Al-Otaibi S. The prevalence of diabetic retinopathy and ssociated risk factors in type 2 diabetes mellitus in Al-Naeemarea (Kuwait). Middle East J Family Med 2005;3(2).
Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable J. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986(35): 1332-1339.